Q4123 identifies AlloSkin RT; Q4115 identifies AlloSkin. Select the code that matches the product furnished.
On this page
CMS RVU26D · Effective 2026-10-01
Q4115 Skin substitute Medicare reimbursement rates in Minnesota
Reports AlloSkin human skin allograft supplied for wound coverage when furnished with a primary wound-treatment procedure. Compare Q4115 office and facility rates across CMS payment localities in Minnesota.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4115 in Minnesota?
Minnesota has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$130.95
1 of 1 localities have a supported rate.
Payment area: Minnesota
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Skin substitute product
About Q4115: AlloSkin skin substitute product
Reports AlloSkin human skin allograft supplied for wound coverage when furnished with a primary wound-treatment procedure.
Q4115 identifies AlloSkin, a human skin allograft product supplied for wound coverage. It may be used by clinicians treating wounds that require biologic skin coverage, including chronic ulcers or surgical wounds. The surgeon, podiatrist, or wound-care clinician applies the product in an outpatient wound-care or surgical setting. This code represents the product, not the work of preparing the wound or applying the graft.
Report Q4115 for the AlloSkin product furnished, using the HCPCS unit measure of one square centimeter and documenting the product, quantity, and treated wound. Pair it with the primary wound-treatment procedure; CMS classifies it as an add-on and places payment within that procedure's global period. This is a technical-component-only code, with interpretation represented by a separate code. The documentation should identify AlloSkin specifically so it is distinguishable from other skin substitute products.
CMS billing rules for Q4115
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4115 compared with similar codes
Office rates for Minnesota, from the same CMS release.
Q4116 identifies AlloDerm, not AlloSkin. The product name in the record determines which product code applies.
15271 reports the application procedure for skin substitute grafts at specified sites and area ranges. Q4115 identifies the AlloSkin product supplied for that treatment.
Compare Q4115 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Minnesota →
Office / nonfacility
$130.95
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4115 in Minnesota.
PPRRVU2026_Oct_nonQPP.csv
18,213
- Code
- Q4115
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
66
- Locality
- Minnesota
- Physician work
- 1.000
- Practice expense
- 1.029
- Malpractice
- 0.296
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 1.029 | 3.9205 |
| Malpractice | 0.00 | × 0.296 | 0.0000 |
| Total RVUs | 3.9205 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Minnesota$130.95
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 1.029 |
| Malpractice | 0 | 0.296 |
(0 × 1 + 3.81 × 1.029 + 0 × 0.296) × $33.4009 = $130.95
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4115 billing questions
Is Q4115 the code for applying the graft?
No. Q4115 identifies the AlloSkin product; report the applicable primary procedure for wound preparation and graft application.
What unit does Q4115 use?
The unit is one square centimeter. Document the AlloSkin quantity furnished and reported.
Can Q4115 be reported by itself?
No. CMS classifies it as an add-on code that must be billed with a primary procedure, with payment within that procedure's global period.
What documentation supports Q4115?
Record the product as AlloSkin, the quantity furnished, the wound treated, and the primary wound-treatment procedure performed.
How does Q4115 differ from Q4123?
Q4115 identifies AlloSkin, while Q4123 identifies AlloSkin RT. Report the code matching the product actually furnished.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
